Science Explorer Back to mapMap
Discussion
Research facility · Wellesley · United States

MedVadis Research

medvadis.com/MedVadis/Home.htmlROR OpenAlex
Research works
9
▼ 26% vs 2018-21
Citations
104
12.1 per fractional work
Top-10% rate
6.8%
all institutions 10.0%
Open access
47%
world 40%
International
19%
world 18%
MedVadis Research

Not ranked overall: MedVadis Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does MedVadis Research work in?

In all years, 83% of research at MedVadis Research is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (78%), Neuroscience (13%), Dentistry (5%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 83.4% of its workMedicine: 7 fractional works · 78.3% of its workPsychiatry and Mental health: 3 fractional works · 29.4% of its workSurgery: 1 fractional works · 8.1% of its workGastroenterology: 1 fractional works · 7.8% of its workPhysiology: 0 fractional works · 5.6% of its workPathology and Forensic Medicine: 0 fractional works · 5.1% of its workNeurology: 0 fractional works · 4.3% of its workImmunology and Allergy: 0 fractional works · 3.9% of its workComplementary and alternative medicine: 0 fractional works · 2.6% of its workAnesthesiology and Pain Medicine: 0 fractional works · 2.1% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.0% of its workEpidemiology: 0 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.3% of its workEmergency Medicine: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.5% of its workDentistry: 0 fractional works · 5.1% of its workOral Surgery: 0 fractional works · 5.1% of its workLife Sciences: 1 fractional works · 16.6% of its workNeuroscience: 1 fractional works · 12.6% of its workSensory Systems: 1 fractional works · 10.7% of its workNeurology: 0 fractional works · 2.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.2% of its workMolecular Biology: 0 fractional works · 2.2% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.9% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workALL ITS WORKMedVadis Research9fractional works, all years
Life Sciences17%Health Sciences83%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 6 fields, with their numbers
    1. Medicine778.3%
    2. Dentistry05.1%
    1. Neuroscience112.6%
    2. Biochemistry, Genetics and Molecular Biology02.2%
    3. Immunology and Microbiology00.9%
    4. Pharmacology, Toxicology and Pharmaceutics00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from MedVadis Research?

The most cited paper from MedVadis Research is "Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study" (MARCELO EDUARDO BIGAL, Lars IH Edvinsson, Alan M. Rapoport et al., 2015), with 264 citations. Next come "Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine" (69) and "Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine" (47).

Most cited papers
#PaperReleasedCitations
1 Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study MARCELO EDUARDO BIGAL, Lars IH Edvinsson, Alan M. Rapoport et al. · The Lancet Neurology 2 Oct 2015 264
2 Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine Egilius L.H. Spierings, Jan Lewis Brandes, David Kudrow et al. · Cephalalgia Open access 12 Oct 2017 69
3 Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine Paul K Winner, Egilius L.H. Spierings, Paul P. Yeung et al. · Headache The Journal of Head and Face Pain Nov 2019 47
4 A Phase I Study of the Safety of the Nutritional Supplement, Active Hexose Correlated Compound, AHCC, in Healthy Volunteers Egilius L.H. Spierings, Hajime Fujii, Buxiang Sun et al. · Journal of Nutritional Science and Vitaminology Open access 2007 43
5 Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study Egilius L.H. Spierings, Xiaoping Ning, Verena Ramirez Campos et al. · Headache The Journal of Head and Face Pain Open access 10 Aug 2021 30
All 19 most cited papers, with filters and sorting

Which research topics does MedVadis Research publish most on?

By volume in 2022-now: Migraine and Headache Studies, Olfactory and Sensory Function Studies, Dental Anxiety and Anesthesia Techniques and Allergic Rhinitis and Sensitization.

Migraine and Headache St…1Migraine and Headache Studies: 1 fractional worksOlfactory and Sensory Fu…1Olfactory and Sensory Function Studies: 1 fractional worksDental Anxiety and Anest…0Dental Anxiety and Anesthesia Techniques: 0 fractional worksAllergic Rhinitis and Se…0Allergic Rhinitis and Sensitization: 0 fractional worksBiomedical Text Mining and Ontologies: 0 fractional worksClinical practice guidelines implementation: 0 fractional worksPain Management and Treatment: 0 fractional worksCardiac Arrest and Resuscitation: 0 fractional worksTraumatic Brain Injury and Neurovascular Disturbances: 0 fractional worksHemodynamic Monitoring and Therapy: 0 fractional works
Psychiatry and Mental healthSensory SystemsOral SurgeryImmunology and Allergy6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Migraine and Headache Studies Psychiatry and Mental health 1 works
  2. 2 Olfactory and Sensory Function Studies Sensory Systems 1 works
  3. 3 Dental Anxiety and Anesthesia Techniques Oral Surgery 0 works
  4. 4 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  5. 5 Biomedical Text Mining and Ontologies Molecular Biology 0 works
  6. 6 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 0 works
  7. 7 Pain Management and Treatment Anesthesiology and Pain Medicine 0 works
  8. 8 Cardiac Arrest and Resuscitation Emergency Medicine 0 works
  9. 9 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works
  10. 10 Hemodynamic Monitoring and Therapy Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.6%not open53.4%

World: 40% of research is openly available.

with international co-authors18.8%domestic only81.2%

World: 18% is written across borders.

How has MedVadis Research's research output changed?

Output in 2022-2025 was 26% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is MedVadis Research as a percentage of every work published that year, 0.000026% in 2024.

still counting0.000020%0.000040%0.000060%MedVadis Research0.0000060% in 202520102020

Fractional works of MedVadis Research over all fractional works that year. How the balance of science has shifted.

Other research institutions in Wellesley

All research institutions in Wellesley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about MedVadis Research. Posts are plain text and can be reported.